What does the future hold for companies supplying and assisting clinical trials?
Visiongain’s “Clinical Trial Supply and Logistics For Pharma 2016-2026,” report predicts the world market for that clinical trial support will reach $19.5 billion in 2020, with revenue expansion from 2016 to 2026.
The updated report provides revenue forecasts to 2026 at overall world market, submarket and national level. It offers analyses on companies supporting drug research and development through 59 tables, 61 charts and interviews with three companies.
New investigation shows what the future holds for pharmaceutical contract research organizations (CROs) and manufacturing contractors (CMOs) supplying products and logistical services for clinical trials. The report also assesses distribution specialists—dispatch and logistics companies—serving pharmaceutical testing.
The seven submarkets supporting pharma clinical trials include the following:
• Manufacturing—with sub forecasting for packaging and for other production
• Logistics and distribution—also with sub forecasts for cold chain logistics and for other services
• Supply chain management
The report identifies trends, challenges and opportunities for companies supplying clinical trial materials and logistical services, and explains what affects that expanding industry, including these influences:
• Active pharmaceutical ingredient (API) production, finished dosage drug manufacturing, comparator sourcing and placebo manufacturing
• Trends in packaging for clinical testing—emerging needs, solutions and innovations, including those for complex pharmaceuticals
• Regulatory standards for clinical trial supply and organization, good manufacturing practices (GMP) and good distribution practices (GDP)
• International differences in regulations—assess leading countries’ needs, including demands of off-shoring drug development
• Globalization—access to new markets and patients, and its effects
• Supply chain security and other technology to improve medical testing.
Pharma R&D trends that will affect the clinical trial supply and logistics market from 2016 to 2026 include more biological and orphan drug development. In turn, demand for clinical-stage cold chain logistics will increase from 2016.
